SUPN - Supernus Profit before interest, taxes and amortization
Supernus Pharmaceuticals focuses on the therapy of psychiatric disorders through long-term R&D projects. The EBITDA breakdown provided by the GURU.Markets service confirms the effectiveness of investments in rare neurobiology specialists. A stable workforce and the hiring of new managers have optimized operating profit, and now 628.93 records a new benchmark for the company's cash flow.
Summary analytical data breakdowns for Supernus (SUPN)
- share price and consensus valuation forecast:
- market capitalization statistics:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Capital Supernus Pharmaceuticals|SUPN - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Supernus Pharmaceuticals, Inc.|SUPN - Company Total Debt|Debt to Net Assets Ratio Supernus|SUPN - Company Long-Term Debt|Current Liabilities Supernus|Intermediate Coverage Ratio supernus.com
- earnings and market ratios statistics:
SUPN - Net Profit|Projected Future Earnings Supernus Pharmaceuticals|SUPN - Price to Earnings Ratio|Future Price to Earnings Multiple supernus.com|SUPN - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Supernus|SUPN - Operating profit EBITDA|Net earnings per share (EPS TTM) Supernus|SUPN - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months supernus.com|SUPN - Earnings growth in current year|Expected net earnings per share growth next year Supernus Pharmaceuticals
Fundamental company valuation:Supernus Corp
Supernus Pharmaceuticals specializes in developing advanced extended-release delivery systems for the therapy of neurological disorders. Monitoring the current EBITDA value allows for an assessment of the actual cash flow from core operations by excluding depreciation and amortization expenses, which helps investors distinguish sustainable growth in operational efficiency from short-term liquidity spikes and avoid the risk of capital freeze when entering a position.
Competitors of Supernus Pharmaceuticals (SUPN)
BIIB (Biogen Idec) - Profit before deduction of interest, taxes, depreciation and amortization|Neurocrine Biosciences - Operating profit EBITDA|Profit before interest, taxes and amortization regencellbioscience.com|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|ACADIA Pharma - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Operating profit before amortization VKTX (Viking Therapeutics Corp)|Operating profit before deduction of amortization CPRX (Catalyst Pharmaceuticals)|Operating profit EBITDA denalitherapeutics.com (DNLI)|Profit before payment of interest, taxes and amortization Harmony Biosciences Holdings, Inc. HRMY|Operating income before deduction of amortization Biohaven Ltd (BHVN)|AMLX: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TRVI (Trevi Corp)|Praxis Precision Medicines (PRAX) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization AVXL (anavex.com)|CBLL (CeriBell) - Operating profit EBITDA|PRTA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ALEC|Operating profit EBITDA Annexon Biosciences Inc. (ANNX)|Profit before payment of interest, taxes and amortization Omeros OMER|Income before deduction of interest, taxes and amortization NGNE|ACIU - Profit before payment of interest, taxes and amortization|Voyager Therapeutics Inc (VYGR) - Operating profit before deduction of amortization|NMRA: Operating profit EBITDA|Scilex Holding Company, Inc. (SCLX) - Operating profit EBITDA|TVGN (Tevogen Bio Holdings) - Operating profit EBITDA|Operating profit before deduction of amortization Alpha Cognition Corp (ACOG)|Operating profit EBITDA CGTX|IKT - Profit before interest, taxes and amortization|Cassava - Operating profit before deduction of amortization|Operating profit EBITDA Assertio Holdings ASRT|COYA: Operating profit before deduction of amortization|Vistagen Therapeutics - Company profit before taxes, interest and amortization|OVID: Operating profit EBITDA|ABOS - Operating income before deduction of amortization|CRVO (CervoMed Inc) - Operating profit EBITDA|Operating profit before deduction of amortization Alterity Therapeutics Ltd (ATHE)|Operating profit EBITDA CLNN|Operating profit EBITDA pepgen.com (PEPG)|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|Relmada Therapeutics Inc - Profit before payment of interest, taxes and amortization|ANVS - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Grace Therapeutics, Inc. GRCE|Firefly Neuroscience, Inc (AIFF) - Profit before payment of interest, taxes and amortization|KLTO - Operating income before deduction of amortization|Operating profit before deduction of amortization NRSN|Operating profit EBITDA Reviva Pharmaceuticals Holdings Inc.|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NRXS: Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|PASG: Operating profit before amortization|NEUP - Profit before payment of interest, taxes and amortization|NERV (Minerva Neurosciences Inc) - Operating profit before amortization|ATHA: Operating profit EBITDA|Profit before interest, taxes and amortization Addex (ADXN)|Operating profit before deduction of amortization ALZN|Operating profit EBITDA Cyclerion|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cortigent CRGT|Avenue Therapeutics Inc (ATXI) - Profit before interest, taxes and amortization|BCLI - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization caratherapeutics.com CARA|CHRO (Chromocell Therapeutics Corp.) - Operating profit before deduction of amortization|Eliem Therapeutics Inc. (ELYM) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Intra-Cellular Therapies Inc.|Longboard - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA MRNS|NKGN - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization NeuroBo Pharmaceuticals, Inc. NRBO|Income before deduction of interest, taxes and amortization SAGE|SNPX - Profit before payment of interest, taxes and amortization|TRVN (Trevena Inc) - Operating profit before amortization|VIGL (vigilneuro.com) - Operating profit before deduction of amortization|anewmeds.com (WENA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
